Skip to main content
. 2017 May 22;6(5):e341. doi: 10.1038/oncsis.2017.41

Figure 3.

Figure 3

AKT inhibition by 3-AWA co-ordinates Par-4/JNK intrication in p21 downmodulation. (a) PC-3 cells were transiently transfected with siRNA control or Par-4 siRNA and then treated with 3-AWA and/or Salubrinal for 24 h. The expression of the indicated proteins was analyzed through western blotting. (b) PC-3 cells were transiently transfected with GFP or GFP-Par-4 and then treated with 3-AWA and/or Thapsigargin for the set time point. The lysates were prepared and subjected to western blotting for the expressional analysis of Par-4, p-JNK, JNK and p21. (c) Immunoblotting analysis of Par-4, p-AKT, AKT and p21 was carried out in PC-3 cells, transiently transfected with GFP or GFP-Par-4, then treated with 3-AWA and/or Thapsigargin or an AKT inhibitor AT7867. (d) Lysates prepared from DU-145 cells, transiently transfected with GFP or GFP-Par-4 following treatment with designated concentrations 3-AWA and/or Thapsigargin or AT7867 for the indicated time point, were subjected to western blotting for the detection of Par-4, p-AKT, AKT, p-JNK, JNK, GRP78 and p21. β-Actin was used as loading control and the data shown are the representative of three independent experiments.